Vinay Prasad, a critic of the Food and Drug Administration, has been tapped as the agency’s top regulator of vaccines, gene ...

"You could replace Peter Marks with a bobblehead doll that just stamps approval and you would have the same outcome at FDA with lower administrative fees," Prasad posted on March ...

At the American Society of Cell and Gene Therapy conference, there were questions and qualms on how Vinay Prasad may change ...

A hot (if cautious) topic at the big gene therapy meeting: what Vinay Prasad's appointment might mean for approvals in rare ...

The Food and Drug Administration (FDA) has tapped Vinay Prasad, a prominent critic of federal COVID-19 policies and a proponent of more stringent approval standards, to lead the agency’s vaccines ...

Vinay Prasad, MD, MPH, a frequent critic of the FDA and COVID-19 lockdowns and vaccination policies, will be the next director of FDA's Center for Biologics Evaluation and Research (CBER), the center ...

In late March, Dr. Peter Marks, the Food and Drug Administration ... Seven weeks later, the FDA named Marks’ successor: Dr. Vinay Prasad, a hematologist and oncologist. That wouldn’t necessarily be a ...

The Food and Drug Administration on Tuesday named Dr. Vinay Prasad — a hematologist ... experience — although Marks, the former vaccine chief, was also criticized for having a background in oncology ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.

The US Food and Drug Administration has named Dr. Vinay Prasad, a hematologist oncologist ... and its vaccine policies during the Covid-19 pandemic. He replaces Dr. Peter Marks, who helped lead the ...